Thus low‐dose of IL‐2 has been found to have a broad therapeutic potential in many autoimmune and inflammatory diseases, like systemic lupus erythematosus (SLE), sjogren syndrome, and various kinds of tumors.6, 7, 8, 9. This evidence concerns the gene IL2 and systemic lupus erythematosus.